Adventris Pharmaceuticals

Private

Baltimore, MarylandHealthcare & Life Scienceshttps://www.adventris.com/

Last Round

Seed

Oct 18, 2024

Total Funding Raised

$12.5M

Company Overview

Adventris Pharmaceuticals is a biotechnology company that develops cancer vaccines designed to train the immune system to recognize and attack cancer-causing mutations.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

cancer vaccinetherapeutic vaccineKRAS mutationoncologybiotechnologydrug discoveryprecision medicineimmunotherapycancer immunotherapyoncogenevaccine platformbiotech startup

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Adventris Pharmaceuticals Comps

Public and private peers based on sector, stage, and business model.

Adventris Pharmaceuticals comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Adventris Pharmaceuticals Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Seed	Oct 18, 2024
Pre Seed	Oct 2, 2023

View all Funding Rounds

Adventris Pharmaceuticals Investors

Notable investors and investment history

Adventris Pharmaceuticals investors
Investor	Rounds
Refactor Capital	Pre Seed
Johns Hopkins Technology Ventures	Pre Seed
Johns Hopkins Technology Ventures	Pre Seed
Y Combinator	Pre Seed

View all Investors

Adventris Pharmaceuticals Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Adventris Pharmaceuticals Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Adventris Pharmaceuticals's valuation, stock price, and market status.

Firmographic Details

HeadquartersBaltimore, Maryland

Employee Range9

Year Founded2022

Last FundingOct 18, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.